0 followers
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Bruce Culleton
4D Molecular Therapeutics
3 followers
FUJIFILM Cellular Dynamics
1 follower
Masuu Global Solutions
1 follower
Mountainside
1 follower
Anteris Technologies
1 follower
Quest Medical, Inc.
1 follower
Lighthouse Worldwide Solutions
1 follower
Cytokinetics
11 followers
Integra LifeSciences
6 followers
Abbott
278 followers
Imprivata
23 followers
Explore companies